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Abstract
The causal assumptions, the study design and the data are the elements required for
scientific inference in empirical research. The research is adequately communicated
only if all of these elements and their relations are described precisely. Causal models
with design describe the study design and the missing data mechanism together with
the causal structure and allow the direct application of causal calculus in the estimation
of the causal effects. The flow of the study is visualized by ordering the nodes of the
causal diagram in two dimensions by their causal order and the time of the observation.
Conclusions whether a causal or observational relationship can be estimated from the
collected incomplete data can be made directly from the graph. Causal models with
design offer a systematic and unifying view scientific inference and increase the clar-
ity and speed of communication. Examples on the causal models for a case-control
study, a nested case-control study, a clinical trial and a two-stage case-cohort study
are presented.
1 Introduction
Causal models are commonly used to describe the true or hypothesized causal rela-
tionships between a set of variables. The model is typically presented as a directed
acyclic graph (DAG), where the nodes represent the variables and the edges represent
the causal relationship so that the arrow shows the direction of the effect. A graphical
model serves as a tool for visualizing and discussing causal relationships but even more
importantly it is a mathematically well-defined object from where causal conclusions
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can be drawn in a systematic way. Causal calculus (Pearl, 1995, 2009) can be used
to estimate causal effects from observational data providing that the study has been
carefully designed (Rubin, 2008).
Causal models are not sufficient for the estimation of causal effects without the
data. After specifying the causal model and the objectives of the study, the first ques-
tions of the researcher should be “How should the data be collected?” and “How
should the data collection be taken into account in the analysis?” (Heckman, 1979;
Rosenbaum and Rubin, 1983). In many fields of science, the data are not obtained
as a simple random sample of the population. The pressure of cost-efficiency leads
to complex study designs where the expensive measurements are made only for a
carefully selected subset of individuals (Reilly, 1996; McNamee, 2002; Langholz, 2007;
Kulathinal et al., 2007; Van Gestel et al., 2000; Karvanen et al., 2009a). It is therefore
crucial to take the study design into account in the estimation of causal effects. The
increased complexity of study designs also emphasizes the need for accurate and effi-
cient reporting (von Elm et al., 2007; Vandenbroucke et al., 2007; Schulz et al., 2010;
Moher et al., 2010).
An introduction to causal models with design is given through an example in Sec-
tion 2. The formal definition of the concept is then presented in Section 3. In Section 4
it is shown how the causal effects can be estimated from a case-control study. Exam-
ples describing a clinical trial, a nested case-control study and a two-stage case-cohort
study as causal models with design are provided in Section 5. Finally, the benefits, the
limitations and the implications of the proposed concept are discussed in Section 6.
2 Introductory example
Pearl (2009) considers an example where the causal effect of smoking X to the lung
cancer Y is studied. It is assumed that the causal effect is mediated through the tar
deposits in the lungs Z. In addition, there might be an unknown confounder U which
has a causal effect both to X and Y but not to Z. Figure 1(a) illustrates the causal
model.
In numerical calculations, Pearl implicitly assumes that the data are obtained as
a simple random sample from the population. This assumption is made explicit in
Figure 1(b). Variable mΩi, where subscript i indexes the individuals, represents an
indicator for a finite well-defined closed population Ω = {1, . . . , N}. It is defined mΩi =
1, i ∈ Ω and mΩi = 0, i /∈ Ω. Variable m1i represents the sampling. This indicator
variable has value 1 if the individual was selected to the sample and 0 otherwise.
The arrow from mΩi to m1i describes the fact that the sample is selected from the
population, i.e. m1i = 1 implies mΩi = 1. The value of m1i can be determined by the
researcher, which is shown in the graph by using diamond symbols for the these nodes.
Variables Xi, Zi and Yi are related to the underlying population and are not di-
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Figure 1: Graphical models for the example on the causal effect of smoking to the lung
cancer
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rectly observed, which is shown in the visualization with the open circles. Instead, the
variables X∗i , Z
∗
i and Y
∗
i are measured from the sample. Because these variables are
observed, they are shown as filled circles. The value of Y ∗i is Yi if the individual belongs
to the sample, i.e. m1i = 1; otherwise Y
∗
i is not available. This is described in the
graph by arrows from m1i and Yi to Y
∗
i . In other words, the causal assumptions, the
study design and the data are all presented in the same graph where the causal effects
are defined consistently regardless of the type of the variable.
Instead of simple random sampling, case-control designs are often used in epidemi-
ology to study rare diseases. Figure 1(c) represents a case-control design where the
selection for the risk factor measurement is made on the basis of the lung cancer status.
In practice, for instance, 1000 lung cancer cases and 1000 non-cases are selected. The
lung cancer status Y ∗i is determined for the sample {i : m1i = 1}. Smoking X
∗
i and tar
deposits Z∗i are measured for the case-control set {i : m2i = 1}. In the graph, there are
arrows from m1i and from Y
∗
i to m2i, which indicates that the selection for case-control
set depends on the measured lung cancer status.
It is well known that the study design must be taken into account in the analysis of
the data from the case-control design. This means that although Figure 1(a) presents
the causal model for both situations (b) and (c), the analysis of the case-control study
(c) differs from the analysis of the simple random sample (b). This difference is made
explicit by combining the study design to the causal model. As these causal models
with design are causal models, the actual estimation of causal effects can be carried
out applying the rules of causal calculus as demonstrated in Section 4.
3 Causal models with design
The formal definition of causal models with design relies on the definition of causal
models as presented by Pearl (2009) and the missing data concept presented by Rubin
(1976). The definition of causal models is extended to reflect the elements of inference:
the causal assumptions, the study design and the data. The immediate benefit is that
the methods of causal calculus are directly applicable for questions related to the study
design and estimation. Graphical models with explicit sampling or selection mechanism
have been earlier used by Cooper (2000), Geneletti et al. (2009), Didelez et al. (2010)
and Bareinboim and Pearl (2012b).
Causal model and probabilistic causal model are defined by Pearl (2009) as follows:
Definition 1 (Structural Causal Model, Pearl 7.1.1) A causal model is a triple
M = 〈U, V, F 〉, where
(i) U is a set of background variables that are determined by factors outside the
model;
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(ii) V is a set {V1, V2, . . . , Vn} of variables, called endogenous, that are determined by
variables in the model – that is, variables U ∪ V ; and
(iii) F is a set of functions {f1, f2, . . . , fn} such that each fi is a mapping from (the
respective domains of) Ui ∪ PAi to Vi where Ui ⊆ U and PAi ⊆ V \ Vi and
the entire set F forms a mapping from U to V . In other words, each fi in
vi = f(pai, ui), i = 1, . . . , n, assigns a value to Vi that depends on (the values
of) a select set of variables in V ∪ U , and the entire set F has a unique solution
V (u).
Definition 2 (Probabilistic Causal Model, Pearl 7.1.6) A probabilistic causal model
is a pair 〈M, P (u)〉 where M is a causal model and P (u) is a probability function de-
fined over the domain of U .
The causal diagram G(M) of a causal model M is a directed graph where each node
corresponds to a variable and the directed edges point from members of PAi and Ui
toward Vi.
Causal model with design can be defined as an extension of the probabilistic causal
model presented by Pearl where the notation for selection and missing data follows the
lines of (Rubin, 1976):
Definition 3 (Causal model with design) Causal model with design is a proba-
bilistic causal model that fulfills the following conditions:
1. Each node in the causal diagram is either a causal node, a selection node or
a data node. Each node has an information type attribute with possible values:
‘observed’,‘not observed’, ‘determined and known’ and ‘determined and unknown’.
2. Each selection node represents a binary variable with the possible values 1 and
0. There is always a unique selection node MΩ (population node) which is an
ancestor of all selection nodes and has value MΩ = 1.
3. Each data node has two parents, one causal node and one selection node. A causal
node cannot be a parent for more than one data node. For a data node X∗ with
parents causal node X and selection node M , it holds
X∗ =
{
X, if M = 1
NA, if M = 0
where NA represents a missing value.
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In the first item of Definition 3, the node types are named and the possible values
information type attributes are listed. The information type attribute of the variable
with the possible values ‘observed’, ‘not observed’ and ‘determined and known’ and
‘determined and unknown’ describes the knowledge of the researcher. In visualizations
these types are presented as a filled circle, an open circle, a filled diamond and an open
diamond, respectively. In an observational setup, a causal variable X is not observed as
such; only the corresponding measurement X∗ is observed. In an experimental setup,
the values of some causal variables can be determined by the researcher. Usually,
causal variables determined by the researcher are known but in principle they can
be also unknown if the information on the values set for the variable has been lost
after the execution of the experiment. The data are by definition always observed. A
selection variable can have all four information types. The value of a selection variable
is determined when sampling or other selection is applied to the population. The
selection variable can be determined and known or determined and unknown. The
latter type, ‘determined and unknown’, may occur, for instance, when the sample is
drawn from administrative register with personal identifiers but these are later removed
from the data and the researcher is not able to tell which individuals of the population
are present in the sample. When the missing data can be identified as an empty record,
the selection variable is observed. If the missing individuals are not identified at all, as
it is the case in left truncation for instance, the selection variable is not observed.
In the second item of Definition 3, the role of the population and the selection
variables is specified. Causal assumptions are always made with respect to some finite
population Ω known as study source in epidemiology (Miettinen, 2011). There is
always only one population node. If there is more than one conceptual population,
the population Ω can be defined as the union of the conceptual populations. The
conceptual population, for instance, a geographical area, becomes a causal variable in
the model. If the causal mechanisms differ by the area, the model contains arrows
from the area to the causal nodes where the functions fj differ between the conceptual
populations. This allows defining models where some causal relationships are similar
across the areas and some are different. The selection probabilities for the sampling
may also differ by the area, which is shown in the model by an arrow from the area to
the selection node.
The members of the population can be a priori known or unknown. In the former
case, the researcher has a unique identifier, for instance, the social security number,
available for each member of the population before the study. In the latter case, the
researcher identifies the members of the population only when they enter to the study.
A selection node M induces the subpopulation {i ∈ Ω |Mi = 1}, which consists of the
selected individuals. The causal effects are typically estimated for the population Ω
but, for instance, in epidemiological cohort studies the effects are often estimated only
for the cohort {i ∈ Ω |Mi = 1}, also known as study base (Miettinen, 2011).
In the third item of Definition 3, the relations of the causal variables, the selection
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variables and the data are specified. The value of random variable Xi is measured only
if the individual i is selected to be measured, which is indicated by the selection variable
Mi. This means that the measured value X
∗
i is a random variable which depends on
the variables Xi and Mi in a deterministic way. The definition of a univariate random
variable is extended so that in addition to real axis, a random variable may also have
a special value ‘NA’ which indicates missing data. With this definition, all elements of
scientific inference can be expressed as random variables and their causal relationships.
If a data node or a selection node has a directed path to a causal node, the measurement
or the selection has a causal effect to the underlying causal variable. This may be the
case, for instance, in health examination studies where the participation to the study
may increase the awareness on the healthy life style and consequently also have an
impact to the later measurements of health indicators.
In a causal model, the causal effects define a partial ordering between the variables.
In addition to this causal time, the time of observation can be linked to each variable
in a causal model with design. Together the causal time and the observational time
define the relative location of each node in a visualization where the causal time is
presented on x-axis and the observational time on y-axis. To make the visualization
more informative, the stages of the study can be used as labels for the y-axis as it is
done in the examples of Sections 2 and 5.
Measurement error can be added to a causal model with design by introducing two
causal variables: the original variable Xi and the version with measurement error X˜i.
In the graph there is an arrow from Xi to X˜i. Both Xi and X˜i are unobserved and only
X˜∗i is observed for the sample. Variable X
∗
i is usually unobserved unless some kind of
benchmark measurements without measurement error are carried out for a subsample.
If two variables Xi and Yi have correlated measurement errors, an explicit unobserved
causal variable U is needed to describe the structure of the measurement error. In the
graph, there are arrows from U to X˜i and to Y˜i in addition to arrows Xi → X˜i and
Yi → Y˜i. Again only X˜
∗
i and Y˜
∗
i are observed for the sample.
In causal models with design, sampling and nonresponse are formally treated in a
similar way; the only difference is the type of the selection node which is ‘determined’
for sampling and ‘observed’ for nonresponse. Some conclusions on the type of missing
data mechanism Rubin (1976) can be made directly from the causal model with design.
LetM to be the selection variable for the measurement Y ∗ of causal variable Y . If there
is no (undirected) path from Y toM except through Y ∗, the data on Y are missing com-
pletely at random (MCAR), more precisely everywhere MCAR (Seaman et al., 2013).
If there is an arrow from Y to M , the data are missing not at random (MNAR). The
traditional MCAR/MAR/MNAR classification concerns the data as a whole whereas
causal models with design provide a description of the missingness mechanism variable
by variable.
Many recent theoretical result on missing data and selection bias in causal inference
can be applied to causal models with design. As these results are not defined directly for
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causal models with design but for other extensions of causal models, transformations are
applied as the first step. Mohan et al. (2013) consider estimation when data are MNAR
and derive conditions a “missingness graph” should satisfy to ensure the existence of a
consistent estimator for a given probabilistic relation. In order to utilize these results,
a causal model with design can be collapsed to a missingness graph by removing the
intermediate selection nodes, i.e. selection nodes that are not parents of a data node.
Formally this can be defined as follows:
Definition 4 (Collapse to a Missingness Graph) Missingness graph H is a col-
lapse of causal model with design M with causal diagram G(M) if (i) the set of nodes
in H consists of the causal nodes of M, the data nodes of M and such selection nodes
of M that are parents of some data node, (ii) there exist an edge from node X to node
Y in H if there exists an edge from X to Y in G(M) or if X is a causal node and Y
is a selection node and there exists a directed path from X to Y in G(M).
The results and algorithms by Bareinboim and Pearl (2012b) can be used to miti-
gate and sometimes to eliminate the selection bias caused by preferential data collec-
tion. The results are applicable in the important special case where a single selection
node (often marked by S) is the parent for all data nodes. In order to apply these
results, a causal model with design is first collapsed to a missingness graph and then
the data nodes are removed. The transformed graph contains the selection node S
and all causal nodes. The results by Didelez et al. (2010), Geneletti et al. (2009) and
Cooper (2000) can be also applied to the same transformed graph.
Bareinboim and Pearl (2013a,b) consider theoretical conditions for the transfer of
experimental results from one or several populations to other populations. Causal
models with design have only one population but the transportability results can be
used between the conceptual populations. The application of the results and the algo-
rithms by Bareinboim and Pearl (2013a,b) requires that the causal model with design
has been collapsed to a selection diagram as follows:
Definition 5 (Collapse to a Selection Diagram for Transportability) Selection
diagram HS is a collapse of causal model with design M with respect to a set of selec-
tion variables S if (i) the conceptual populations of M are identified by the variables
of S (ii) the set of nodes in HS consist of the causal nodes of M (iii) there exist an
edge from node X to node Y in HS if there exists an edge from X to Y in G(M) and
Y does not belong to S.
Other recent developments that can be applied to causal models with design in-
clude the results on the testability of counterfactuals (Shpitser and Pearl, 2007) and
z-identifiability of surrogate experiments (Bareinboim and Pearl, 2012a).
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4 Estimation of causal effects
The following steps are required to estimate causal effects using causal models with
design:
1. Specify the causal model.
2. Check the identifiability of the causal effect in the causal model using the results
by Tian and Pearl (2002), Shpitser and Pearl (2006b,a) and Bareinboim and Pearl
(2012a). If the effect can be identified, use the rules of causal calculus (Pearl,
1995, 2009) to express the causal effect in terms of observed probabilities.
3. Expand the causal model to the causal model with design.
4. Form the likelihood according to the causal model with design and integrate it
over the unobserved variables.
5. Estimate the parameters needed to calculate the causal effect as derived in Step
2.
Causal models with design allow the estimation of causal effects in complex designs
using only the rules of causal calculus and the likelihood. This requires, however,
that the causal effect can be expressed in terms of observed probabilities (Step 2)
and the parameters of the likelihood can be estimated (Step 5). Even if a causal
effect is not identifiable in the general nonparametric form it may still be identifiable
under a specific parametric model. For example, an instrumental variable may help to
identify a causal effect in a linear model but not in a nonlinear model (Pearl, 2009)
and the average causal effect in clinical trials with noncompliance can be identified
under specific assumptions (Angrist et al., 1996). Even if a causal effect is identifiable
in the general nonparametric form, it may not be estimable from the collected data.
A well-known example is the MNAR situation where a variable has a causal effect
on its selection variable and the estimation is not possible in general without strong
assumptions on the selection mechanism (Little and Rubin, 2002).
As an example of the estimation procedure, the smoking and lung cancer example
of Section 2 is considered again. The causal model is specified in Figure 1(a) (Step
1). The goal is the estimate the causal effect p(y | do(X = x)) where the do-operator
represents action/intervention. The result (Step 2)
p(y | do(X = x)) =
∑
z
p(z | X = x)
∑
x′
p(y | X = x′, Z = z)p(X = x′) (1)
is obtained applying the following three rules of causal calculus (Pearl, 1995, 2009):
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1. Insertion and deletion of observations:
p(y | do(x), z, w) = p(y | do(x), w),
if (Y ⊥ Z | X,W ) in the graph GX .
2. Exchange of action and observation:
p(y | do(x), do(z), w) = p(y | do(x), z, w),
if (Y ⊥ Z | X,W ) in the graph GXZ .
3. Insertion and deletion of actions:
p(y | do(x), do(z), w) = p(y | do(x), w),
if (Y ⊥ Z | X,W ) in the graph GXZ(W ),
where Z(W ) is the set of the Z-nodes that are not ancestors of any W -node in
the graph GX .
Here GX represents a graph where the incoming edges of the set of nodes X are
removed, GX represents a graph where the outgoing edges of the set of nodes X are
removed and GXZ represents a graph where the incoming edges of the X-nodes and the
outgoing edges of the Z-nodes are removed. The rules of causal calculus are sufficient
for deriving all identifiable causal effects from observational data (Huang and Valtorta,
2006; Shpitser and Pearl, 2006b) and experimental data (Bareinboim and Pearl, 2012a)
for a given population. Alternatively, the back-door and front-door criteria (Pearl,
2009) and the moralization (Lauritzen et al., 1990) can be also used to derive formulas
for the causal effects. Algorithms for the automated application of causal calculus have
been developed (Tian and Pearl, 2002; Huang and Valtorta, 2006; Shpitser and Pearl,
2006b; Bareinboim and Pearl, 2012a).
Next consider the case-control design of Figure 1(c) (Step 3). To estimate the causal
effects, the model parameters must be estimated from the data collected according to
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this design. The likelihood can be factorized according to the graphical model
p(mΩ,m1,m2,Z,X,Y,U,Z
∗,X∗,Y∗ | θ,ψ) =
N∏
i=1
p(mΩi)p(m1i | mΩi,ψ)p(Ui)p(Xi | Ui, θ)p(Zi | Xi, θ)p(Yi | Zi, Ui, θ)
× p(m2i | m1i, Yi,ψ) =∏
{i:m2i=1}
p(m1i = 1 | mΩi,ψ)p(Ui)pX(X
∗
i | Ui, θ)pZ(Z
∗
i | Xi = X
∗
i , θ)pY (Y
∗
i | Zi = Z
∗
i , Ui, θ)
× p(m2i = 1 | m1i = 1, Y
∗
i ,ψ)∏
{i:m2i=0,m1i=1}
p(m1i = 1 | mΩi,ψ)p(Ui)p(Xi | Ui, θ)p(Zi | Xi, θ)pY (Y
∗
i | Zi, Ui, θ)
× p(m2i = 0 | m1i = 1, Y
∗
i ,ψ)∏
{i:m1i=0}
p(m1i = 0 | mΩi,ψ)p(Ui)p(Xi | Ui, θ)p(Zi | Xi, θ)pY (Yi | Zi, Ui, θ),
where θ represents the model parameters, ψ represents parameters related to the design
and the vector notation, such as m1 = (m11, . . . , m1N )
T , refers to the variables for all
individuals {1, . . . , N} in the population. The distributions are defined with respect
to the first argument unless otherwise specified. The likelihood of the observed data is
obtained as an integral over the unknown variables Z, X, Y and U (Step 4)
p(mΩ,m1,m2,Z
∗,Y∗,X∗ | θ,ψ) =∏
{i:m2i=1}
p(m1i = 1 | mΩi,ψ)pX(X
∗
i | θ)pZ(Z
∗
i | Xi = X
∗
i , θ)pY (Y
∗
i | Zi = Z
∗
i , Xi = X
∗
i , θ)
× p(m2i = 1 | m1i = 1, Y
∗
i ,ψ)∏
{i:m2i=0,m1i=1}
p(m1i = 1 | mΩi,ψ)pY (Y
∗
i | θ)
× p(m2i = 0 | m1i = 1, Y
∗
i ,ψ)∏
{i:m1i=0}
p(m1i = 0 | mΩi,ψ). (2)
As the selection m1 is random sampling from the population, the term p(m1i = 0 |
mΩi,ψ) may be ignored in the estimation of θ. The selection m2 depends on the
response Y and the term p(m2i = 0 | m1i = 1, Y
∗
i ,ψ) must not be ignored. Note also
that although X is not a parent of Y in the causal model, the likelihood (2) has the
term p(Y = 1 | X = x, Z = z).
In Step 5 the likelihood must be written in a parametric form. Finding a good
parametrization, i.e. finding a good statistical model, is purely a statistical problem.
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Causal considerations are not needed in the model selection or in the parameter esti-
mation and the vast literature on these topics is directly applicable. It follows from
equation (1) that the probabilities p(x), p(z | X = x) and p(y | X = x, Z = z) are
needed to estimate p(y | do(X = x)). The same probabilities are also components
in the likelihood (2) and it is therefore natural to parametrize them. For simplicity
Pearl (2009) assumes that the variables X , Z and Y have possible values 0 and 1. The
observed probabilities mentioned above can be now parametrized as follows:
p(X = 1) = θX ,
p(Z = 1 | X = x) = θZ + xθZX ,
p(Y = 1 | X = x, Z = z) = θY + xθY X + zθY Z + xzθY ZX .
With this parametrization, the causal effect of smoking to the risk of lung cancer given
by equation (1) can be written as
p(Y = 1 | do(X = 1)) =(θZ + θZX)
(
θX(θY + θY X + θY Z + θY ZX)+
(1− θX)(θY + θY Z)
)
+
(1− θZ − θZX)
(
θX(θY + θY X) + (1− θX)θY
)
(3)
p(Y = 1 | do(X = 0)) =θZ
(
θX(θY + θY X + θY Z + θY ZX) + (1− θX)(θY + θY Z)
)
+
(1− θZ)
(
θX(θY + θY X) + (1− θX)θY
)
. (4)
These equations link the model parameters θ = (θX , θZ , θY , θZX , θY X , θY Z , θY ZX) to the
causal effects. The dependency of the selection probability on Y ∗ may be parametrized
as
p(m2 = 1 | Y
∗ = y) = ψ + yψY .
As the variables are binary, the data collected according to the case-control design
can be presented in the form of frequencies given in Table 1. The size of the population
is N = N11 + N10 + N01 + N01 where N11 is the number of cases selected, N10 is the
number of non-cases selected, N01 is the number of cases not selected and N00 is the
number of non-cases not selected. In the other words, it is assumed that the lung
cancer prevalence in the population is known. The log-likelihood derived from the
likelihood (2) becomes
n1·· log θX + n0·· log(1− θX) + n11· log(θZ + θZX) + +n01· log(θZ)+
n10· log(1− θZ − θZX) + n00· log(1− θZ)+
n111 log(θY + θY X + θY Z + θY ZX) + n101 log(θY + θY X) + n101 log(θY + θY Z)+
n001 log(θY ) + n110 log(1− θY − θY X − θY Z − θY ZX)+
n100 log(1− θY − θY X) + n010 log(1− θY − θY Z) + n000 log(1− θY )+
N01 log(θ
′
Y ) +N00 log(1− θ
′
Y )+
N11 log(ψ + ψY ) +N10 log(ψ) +N01 log(1− ψ − ψY ) +N00 log(1− ψ),
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where · represents summation over the corresponding marginal and
θ′Y = p(Y = 1) =(1− θX)(1− θZ)θY + θX(1− θZ − θZX)(θY + θY X)+
(1− θX)θZ(θY + θY Z) + θX(θZ + θZX)(θY + θY X + θY Z + θY ZX)
is a shorthand notation for the marginal probability of Y . The maximum likelihood es-
timates of θ can be obtained by numerical optimization of the log-likelihood. Naturally,
a Bayesian analysis may be carried out as well.
Table 1: Data collected from the case-control study
Notation Numerical illustration
Y = 1 Y = 0 Y = 1 Y = 0
X = 0, Z = 0 n001 n000 100 814
X = 1, Z = 0 n101 n100 47 5
X = 0, Z = 1 n011 n010 3 45
X = 1, Z = 1 n111 n110 850 136
sum N11 N10 1000 1000
For a numerical illustration, consider a case-control study where 1000 lung cancer
cases and 1000 controls are selected for the covariate measurements. The parameters
θ are set according to the (unrealistic) population probabilities used in (Pearl, 2009,
page 84). The expected frequencies are shown in Table 1. With these frequencies and
the numbers of non-selected individuals N01 = 8500 and N00 = 9500, the maximum
likelihood estimates θˆX = 0.50, θˆY = 0.10, θˆZ = 0.050, θˆZX = 0.90, θˆY Z = −0.043,
θˆY X = 0.79, θˆY ZX = −0.0019, ψˆ = 0.095, ψˆY = 0.010 and θˆ
′
Y = 0.48 are obtained. The
equations (3) and (4) give the causal effects
p(Y = 1 | do(X = 1)) = 0.456
p(Y = 1 | do(X = 0)) = 0.495,
which are similar to the causal effects estimated from the whole population in (Pearl,
2009, page 84). The differences in the third decimal are due to the rounding of the
expected frequencies in Table 1 to the nearest integer.
5 Examples with complex study design
The examples presented in this section aim to demonstrate how causal models with
design can describe the essential features of complex experimental and observational
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studies in a precise and illustrative way. The examples are from medicine and epidemi-
ology where complex study designs are commonly used. The first example is based
on a real study and causal models with design are used to make conclusions on the
identifiability of various causal effects from data missing not at random. The two other
examples describe imaginary but realistic scenarios.
Causal graphs with design remove the ambiguity related to the common names of
study designs such retrospective study, prospective study, cohort study, case-control
study and two-stage study (Vandenbroucke, 1991; Knol et al., 2008). The process of
the data collection can be seen directly from the causal graph with design.
For the estimation of causal effects, the procedure presented in Section 4 is appli-
cable. Causal models with design are also useful in the estimation of predictive models
when the study design and the missing data mechanism must be taken into account in
the analysis. The likelihood factorized according to the causal model with design offers
a natural starting point for the parameter estimation in both the frequentist and the
Bayesian approach. The idea is to write first the full likelihood for the data, the design
and the latent variables, and then see which parts of the likelihood are not needed
in the estimation of the parameters of the interest. The likelihood functions for the
examples of this section are given in Appendix.
Figure 2 illustrates a causal model with design for the two-stage case-cohort de-
sign used in the MORGAM Project (Kulathinal et al., 2007; Evans et al., 2005). The
project aims to estimate the impact of classic and genetic risk factors to the risk of
cardiovascular diseases. Currently 15 cohorts from 6 countries participate in the ge-
netic component of the project. Most of the cohorts are selected as random samples
of the underlying population of certain age range, typically 24–65 years although there
is variation between the cohorts. Over 50,000 individuals have been examined for the
classic risk factors and followed up for mortality and disease endpoints. Due to the
cost of genotyping, genes have been measured only for a subset of each cohort. Over
10,000 individuals have been genotyped in the case-cohort setting.
The causal assumptions are described using four variables: genetic risk factors
Zi, classic risk factors Xi and health status at baseline Y0i and at the end of the
follow-up Yi. Here classic risk factors are understood to include the actual risk factors
such as smoking, cholesterol and blood pressure as well as all relevant background
variables measured at baseline. The internal causal structure between these variables
is not specified because it is not needed in the following considerations. From the
graph it can be read that genes may affect the disease risk directly and via classic risk
factors. Classic risk factors measured at baseline may be affected by the health status
at baseline. The following conclusions can be made using causal calculus:
1. The causal effect of genes to disease corresponds to the observed effect in the
population
p(Y | do(Z = z)) = p(Y | Z = z).
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2. The causal effect of classic risk factors to disease in the population is confounded
by genes and health status at baseline
p(Y | do(X = x)) =
∫ ∫
p(Y | X = x, Z = z, Y0 = y0)p(Z = z, Y0 = y0)dzdy0.
(5)
3. The causal effect of classic risk factors to disease conditioned on health status at
baseline is confounded by genes
p(Y | do(X = x), Y0 = y0) =
∫
p(Y | X = x, Z = z, Y0 = y0)p(Z = z | Y0 = y0)dz.
(6)
4. Causal effect of genes, classic risk factor and health status at baseline corresponds
to the observed conditional effect in the population
p(Y | do(Z = z), do(Y0 = y0), do(X = x)) =
p(Y | Z = z, do(Y0 = y0), do(X = x)) =
p(Y | Z = z, Y0 = y0, do(X = x)) = p(Y | Z = z, Y0 = y0, X = x).
In order to see whether these effects can be estimated from the collected data,
the study design need to be investigated. The population is defined to include all
individuals living in a specified geographical area and born in specified years. However,
the sampling frame is not the birth cohort but the individuals alive at baseline. In other
words, individuals who have died before baseline are left truncated. In the graph this
left truncation is shown by an arrow from Y0i to the unobserved selection node M0i.
Sampling, denoted by node m1i, is carried out and each selected individual makes
a decision on the participation M1i. This decision depends on health status Y0i ,
socio-economic status and classic risk factors Xi (Chou et al., 1997; Hara et al., 2002;
Cohen and Duffy, 2002; Jousilahti et al., 2005; Drivsholm et al., 2006; Knudsen et al.,
2010; Alkerwi et al., 2010). The data are MNAR because the fact whether Xi and
Y0i are measured depend on the values of these variables. However, the missingness
mechanism may still be ignorable in some analyses. Applying d-separation to causal
model with design it can be concluded that
M1i 6⊥ Yi | Zi (7)
M1i 6⊥ Yi | Zi, Y0i (8)
M1i ⊥ Yi | Xi, Y0i (9)
M1i ⊥ Yi | Zi, Xi, Y0i. (10)
From result (7) it follows that the cohort data (and consequently the case-cohort data)
cannot be used to estimate the causal (or predictive) effect genetic risk factors to
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disease in the population without accounting for the missingness mechanism. Result (8)
tells that conditioning on the health status at baseline does not change the situation
qualitatively. From result (9) it follows that the cohort data can be used to estimate
the predictive model p(Yi | Xi = xi, Y0i = y0i) for the healthy population. This kind
of conditioning on the health status is commonly used in epidemiology and has been
applied also in the MORGAM Project, e.g. in (Asplund et al., 2009). To estimate the
causal effects of classic risk factors in the population, the missingness mechanism must
be taken into account because equation (5) contains the distribution p(Z = z, Y0 = y0),
which is potentially different for participants and non-participants. Similarly, the term
p(Z = z | Y0 = y0) in equation (6) implies that the missingness mechanism must be
taken into account also when the causal effects of classic risk factors are estimated for
the healthy population. From result (10) it follows that the case-cohort data can be
used to estimate the causal effect of genetic risk factors for the healthy population on
the condition of classic risk factors. As the case-cohort selectionM2i depends on Y , the
case-cohort selection should be taken into account in the estimation (Kulathinal et al.,
2007; Kulathinal and Arjas, 2006).
The data on health status at baseline Y ∗0i includes information on non-fatal cardio-
vascular events before baseline. Restricting the analysis to the individuals healthy at
baseline, i.e. removing individuals with prior non-fatal events, discards a considerable
amount of potentially useful data. In the MORGAM Project, several attempts have
been made to use these so called baseline cases. In (Karvanen et al., 2009b) baseline
cases are analyzed separately. The joint analysis of baseline cases and follow-up cases
requires compensation for the left truncation, which can be done using nonparamet-
ric imputation (Karvanen et al., 2010) or conditional likelihood (Saarela et al., 2009).
These works, however, do not take the non-participation into account.
Figure 3 shows how the experimental setup of a clinical trial can be described in
a causal model with design. The treatment in the clinical trial is a causal variable
determined by the researcher by the means of randomization. In the graph, this is
presented by causal node T ′i which has the type determined and known. The example
also demonstrates the compliance problem encountered in clinical trials: the actual
treatment may differ from the allocated treatment if the participant does not follow
the instructions given. In the graph, there is an arrow from T ′i to the actual treatment
Ti and T
′
i affects outcome Yi only through Ti. In the intention-to-treat analysis, the
observed outcome Y ∗i is explained by the intended treatment T
′
i using all included
participants in the trial {i : m2i = 1}. In the per-protocol analysis, only the compliant
participants with T ′i = T
∗
i are included.
Figure 4 illustrates a situation where there is a dependence structure between the
selection variables of the individuals in the sample. In a nested case-control design, the
controls are selected considering the individuals at risk at the time (age or calendar
time) of the disease event. A control may later become a case which creates a compli-
cated dependence structure between the selection probabilities (Saarela et al., 2012).
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Figure 2: Causal model with design for the two-stage case-cohort design used in the
MORGAM Project (Kulathinal et al., 2007; Evans et al., 2005). The sampling frame
{i : M0i = 1} is conditioned on the health status Y0i at the beginning of the study
and this dependence must be taken into account when estimates for the population {i :
mΩi = 1} are required. At the first stage of the study, a random sample {i : m1i = 1} is
selected. The decision to participateM1i may depend on classic risk factors and current
health status. Classic risk factors X∗i and current health status Y
∗
0i are measured at the
beginning of the study for the cohort members {i :M1i = 1}. Blood samples taken at
the baseline are frozen to be used later. After a follow-up period of 10 years or more,
the selection for the second stage is made on the basis of the measurements X∗i and Y
∗
i .
All disease cases and an age-stratified random subset of the cohort are selected to the
case-cohort set {i : m2i = 1} for which genetic factors Z
∗
i are measured. Nonresponse
M2i occurs due to missing or contaminated samples or other technical reasons.
Consequently, the selection probability for individual i depends on the covariates and
outcomes of all other individuals. In the graphical presentation drawn for individual i,
the case-control selection node m2i has incoming arrows from X
∗
i , Yi, Xj and Yj where
index j is used to refer to all other individuals.
6 Discussion
Causal models with design offer a systematic and unifying view to scientific inference.
They present the causal assumptions, the study design and the data collection in a way
that accounts for the complexity encountered in real-world problems. The examples
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Figure 3: Causal model with design for a clinical trial. A sample {i : m1i = 1} is
selected for screening from the population {i : mΩi = 1}. The inclusion for the trial
m2i is based on the screening variable Z
∗
i . At the baseline, covariate X
∗
i is measured
for the trial participants and a randomized decision on the treatment T ′i is made. The
actual treatment Ti during the treatment period may differ from the intended treatment
T ′i because of non-compliance. The outcome Yi depends on the covariate Xi and the
treatment Ti. At the end of the treatment period, measurements for the observed
outcome Y ∗i and the observed treatment T
∗
i are made.
in Section 5 demonstrate how the concept can be used to describe medical studies
with multiple stages. Conclusions whether a causal or observational relationship can
be estimated from the collected incomplete data can be made directly from the graph
as it was demonstrated with the MORGAM Project. Despite the complex design,
the estimation of the causal effects can be carried out in a systematic way via causal
calculus as illustrated in Section 4.
Causal models with design present the population and the selection as intrinsic
parts of the model. Selection nodes may have both incoming and outgoing connections
to other nodes. A distinction is made between a random variable and its measured
value. Combined with the selection this allows the description of various sampling and
missing data setups in terms of causal effects.
The limitations of the causal model with design are in many ways similar to the
limitations of the causal models in general. The presentation of causal assumptions
in the form of a graphical model has the benefit that many problems can be solved
without specifying the parameters of the model. On the other hand, the explicit para-
metric definition of the functional relationships is still the only decisive presentation
of the model. Certain causal effects may be identifiable only under specific parametric
assumptions such as linearity of the effect.
The implications of the concept are two-fold. First, it ties together causality and
study design and opens new possibilities for the practical application of graphical mod-
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Figure 4: Causal model with design for a nested case-control study. The idea of the
case-control design is to select the individuals for the measurement of the expensive
risk factor Zi on the basis the outcome Yi and the inexpensive risk factor Xi. At the
first stage, a sample {i : m1i = 1} is selected from the population {i : mΩi = 1} and
variables X∗i and Y
∗
i are measured. The selection of cases and controls m2i depends not
only on measurements of individual i, X∗i and Y
∗
i , but also on the outcome Y
∗
j and the
covariate X∗j of all other individuals in the sample. Each individual has a similar causal
graph which has been omitted in the figure. The nonresponse M2i reflects the fact the
measurement Z∗i may not be available for all individuals selected to the case-control
set.
19
els. Second, it shows the key elements of the study in a compact visual format and thus
increases the clarity and speed of communication. High standards of design, analysis
and communication of scientific studies will significantly reduce the time and effort
needed for the synthesis of scientific knowledge.
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Appendix: Likelihood factorizations
In this section, likelihood functions are presented for the examples of Section 5. The
likelihood functions are derived for the population {i : mΩi = 1} with the size N start-
ing from the factorization that follows directly from the DAG. At the first step, the
likelihood function is written assuming that all variables are observed for the whole
population. The measurements are redundant in this case because they are determin-
istic functions of the causal variables and the selection variables. The measurements
becomes explicit when the likelihood function is further factorized according to the se-
lection variables. Finally, the likelihood of the observed data is obtained as an integral
over the unknown causal variables.
Parameters θ define the distribution of the causal variables and parameters ψ
define the distribution of the selection variables. A vectorized notation similar to
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X = (X1, X2, . . . , XN)
T is used for all variables and the distributions are defined with
respect to the first argument unless otherwise specified.
The likelihood function for the MORGAM Project case-cohort design presented in
Figure 2 has the form
p(mΩ,M0,m1,M1,m2,M2,Z,X,Y0,Y,Z
∗,X∗,Y∗0,Y
∗ | θ,ψ) =
N∏
i=1
p(mΩi)p(Zi | θ)p(Y0i | Zi, θ)p(M0i | mΩi, Y0i,ψ)p(m1i |M0i,ψ)p(M1i | m1i, Xi, Y0i,ψ)
× p(Xi | Zi, θ)p(Yi | Zi, Y0i, Xi, θ)p(m2i | M1i, Y0i, Yi, Xi,ψ)p(M2i | m2i,ψ) =∏
{i:M2i=1}
pZ(Z
∗
i | θ)pY0(Y
∗
0i | Zi = Z
∗
i , θ)p(M0i = 1 | mΩi, Y0i = Y
∗
0i,ψ)p(m1i = 1 |M0i = 1,ψ)
× p(M1i = 1 | m1i = 1, Xi = X
∗
i , Y0i = Y
∗
0i,ψ)pX(X
∗
i | Zi = Z
∗
i , θ)
× pY (Y
∗
i | Zi = Z
∗
i , Y0i = Y
∗
0i, Xi = X
∗
i , θ)
× p(m2i = 1 | M1i = 1, Y
∗
0i, Y
∗
i , X
∗
i ,ψ)p(M2i = 1 | m2i = 1,ψ)∏
{i:M2i=0,m2i=1}
p(Zi | θ)pY0(Y
∗
0i | Zi, θ)p(M0i = 1 | mΩi, Y0i = Y
∗
0i,ψ)p(m1i = 1 | M0i = 1,ψ)
× p(M1i = 1 | m1i = 1, Xi = X
∗
i , Y0i = Y
∗
0i,ψ)pX(X
∗
i | Zi, θ)pY (Y
∗
i | Zi, Y0i = Y
∗
0i, Xi = X
∗
i , θ)
× p(m2i = 1 | M1i = 1, Y
∗
0i, Y
∗
i , X
∗
i ,ψ)p(M2i = 0 | m2i = 1,ψ)∏
{i:m2i=0,M1i=1}
p(Zi | θ)pY0(Y
∗
0i | Zi, θ)p(M0i = 1 | mΩi, Y0i = Y
∗
0i,ψ)p(m1i = 1 | M0i = 1,ψ)
× p(M1i = 1 | m1i = 1, Xi = X
∗
i , Y0i = Y
∗
0i,ψ)pX(X
∗
i | Zi, θ)pY (Y
∗
i | Zi, Y0i = Y
∗
0i, Xi = X
∗
i , θ)
× p(m2i = 0 | M1i = 1, Y
∗
0i, Y
∗
i , X
∗
i ,ψ)∏
{i:M1i=0,m1i=1}
p(Zi | θ)p(Y0i | Zi, θ)p(M0i = 1 | mΩi, Y0i,ψ)p(m1i = 1 | M0i = 1,ψ)
× p(M1i = 0 | m1i = 1, Xi, Y0i,ψ)p(Xi | Zi, θ)p(Yi | Zi, Y0i, Xi, θ)∏
{i:m1i=0,M0i=1}
p(Zi | θ)p(Y0i | Zi, θ)p(M0i = 1 | mΩi, Y0i,ψ)p(m1i = 0 | M0i = 1,ψ)
× p(Xi | Zi, θ)p(Yi | Zi, Y0i, Xi, θ)∏
{i:M0i=0}
p(Zi | θ)p(Y0i | Zi, θ)p(M0i = 0 | mΩi, Y0i,ψ)p(Xi | Zi, θ)p(Yi | Zi, Y0i, Xi, θ).
The likelihood of the observed data is obtained as an integral over the unknown vari-
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ables Z, X, Y0 and Y:
p(mΩ,M0,m1,M1,m2,M2,Z
∗,X∗,Y∗0,Y
∗ | θ,ψ) =∏
{i:M2i=1}
pZ(Z
∗
i | θ)pY0(Y
∗
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∗
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× p(M1i = 1 | m1i = 1, Xi = X
∗
i , Y0i = Y
∗
0i,ψ)pX(X
∗
i | Zi = Z
∗
i , θ)
× pY (Y
∗
i | Zi = Z
∗
i , Y0i = Y
∗
0i, Xi = X
∗
i , θ)
× p(m2i = 1 | M1i = 1, Y
∗
0i, Y
∗
i , X
∗
i ,ψ)p(M2i = 1 | m2i = 1,ψ)∏
{i:M2i=0,m2i=1}
∫
p(Zi | θ)pY0(Y
∗
0i | Zi, θ)pX(X
∗
i | Zi, θ)pY (Y
∗
i | Zi, Y0i = Y
∗
0i, Xi = X
∗
i , θ)dZi
× p(M0i = 1 | mΩi, Y0i = Y
∗
0i,ψ)p(m1i = 1 |M0i = 1,ψ)
× p(M1i = 1 | m1i = 1, Xi = X
∗
i , Y0i = Y
∗
0i,ψ)
× p(m2i = 1 | M1i = 1, Y
∗
0i, Y
∗
i , X
∗
i ,ψ)p(M2i = 0 | m2i = 1,ψ)∏
{i:M1i=0,m1i=1}
∫ ∫ ∫ ∫
p(Zi | θ)p(Y0i | Zi, θ)p(M0i = 1 | mΩi, Y0i,ψ)p(Xi | Zi, θ)
× p(Yi | Zi, Y0i, Xi, θ)p(M1i = 0 | m1i = 1, Xi, Y0i,ψ) dZi dXi dY0i dYi p(m1i = 1 | M0i = 1,ψ)∏
{i:m1i=0,M0i=1}
∫ ∫ ∫ ∫
p(Zi | θ)p(Y0i | Zi, θ)p(M0i = 1 | mΩi, Y0i,ψ)p(Xi | Zi, θ)
× p(Yi | Zi, Y0i, Xi, θ) dZi dXi dY0i dYi p(m1i = 0 | M0i = 1,ψ)∏
{i:M0i=0}
∫ ∫ ∫ ∫
p(Zi | θ)p(Y0i | Zi, θ)p(M0i = 0 | mΩi, Y0i,ψ)p(Xi | Zi, θ)
× p(Yi | Zi, Y0i, Xi, θ) dZi dXi dY0i dYi.
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The likelihood function for the clinical trial presented in Figure 3 has the form
p(mΩ,m1,m2,Z,X,Y,T,T
′,Z∗,X∗,Y∗,T∗ | θ,ψ) =
N∏
i=1
p(mΩi)p(m1i | mΩi,ψ)p(Zi | θ)p(m2i | m1i, Zi,ψ)p(Xi | θ)
× p(T ′i | m2i,ψ)p(Ti | T
′
i , θ)p(Yi | Xi, Ti, θ) =∏
{i:m2i=1}
p(m1i = 1 | mΩi,ψ)pZ(Z
∗
i | θ)p(m2i = 1 | m1i = 1, Z
∗
i ,ψ)
× pX(X
∗
i | θ)p(T
′
i | m2i = 1,ψ)pT (T
∗
i | T
′
i , θ)pY (Y
∗
i | Xi = X
∗
i , Ti = T
∗
i , θ)∏
{i:m2i=0,m1i=1}
p(m1i = 1 | mΩi,ψ)pZ(Z
∗
i | θ)p(m2i = 0 | Z
∗
i ,ψ)pX(Xi | θ)
× pT (Ti | θ)pY (Yi | Xi, Ti, θ)∏
{i:m1i=0}
p(m1i = 0 | mΩi,ψ)pZ(Zi | θ)pX(Xi | θ)pT (Ti | θ)pY (Yi | Xi, Ti, θ).
The likelihood of the observed data is obtained as an integral over the unknown vari-
ables Z, X, T and Y:
p(mΩ,m1,m2,T
′,Z∗,Y∗,X∗,T∗ | θ,ψ) =∏
{i:m2i=1}
p(m1i = 1 | mΩi,ψ)pZ(Z
∗
i | θ)p(m2i = 1 | m1i = 1, Z
∗
i ,ψ)pX(X
∗
i | θ)
× p(T ′i | m2i = 1,ψ)pT (T
∗
i | T
′
i , θ)pY (Y
∗
i | Xi = X
∗
i , Ti = T
∗
i , θ)∏
{i:m2i=0,m1i=1}
p(m1i = 1 | mΩi,ψ)pZ(Z
∗
i | θ)p(m2i = 0 | Z
∗
i ,ψ)
∏
{i:m1i=0}
p(m1i = 0 | mΩi,ψ).
Only the first part of the likelihood is needed to estimate the effect of the treatment
to the outcome.
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The likelihood for the nested case-control study presented in Figure 4 has the form
p(mΩ,m1,m2,Z,X,Y,Z
∗,X∗,Y∗ | θ,ψ) =
N∏
i=1
p(mΩi)p(m1i | mΩi,ψ)p(Zi | θ)p(Xi | θ)p(Yi | Zi, Xi, θ)
× p(m2i | m1i, Xi, Yi,X,Y,ψ)p(M2i | m2i,ψ) =∏
{i:M2i=1}
p(m1i = 1 | mΩi,ψ)pZ(Z
∗
i | θ)pX(X
∗
i | θ)pY (Y
∗
i | Zi = Z
∗
i , Xi = X
∗
i , θ)
× p(m2i = 1 | m1i = 1, X
∗
i , Y
∗
i ,X
∗,Y∗,ψ)p(M2i = 1 | m2i = 1,ψ)∏
{i:M2i=0,m2i=1}
p(m1i = 1 | mΩi,ψ)p(Zi | θ)pX(X
∗
i | θ)pY (Y
∗
i | Zi, Xi = X
∗
i , θ)
× p(m2i = 1 | m1i = 1, X
∗
i , Y
∗
i ,X
∗,Y∗,ψ)p(M2i = 0 | m2i = 1,ψ)∏
{i:m2i=0,m1i=1}
p(m1i = 1 | mΩi,ψ)p(Zi | θ)pX(X
∗
i | θ)pY (Y
∗
i | Zi, Xi = X
∗
i , θ)
× p(m2i = 0 | m1i = 1, X
∗
i , Y
∗
i ,X
∗,Y∗,ψ)∏
{i:m1i=0}
p(m1i = 0 | mΩi,ψ)p(Zi | θ)p(Xi | θ)p(Yi | Zi, Xi, θ).
The likelihood of the observed data is obtained as an integral over the unknown vari-
ables Z, X and Y
p(mΩ,m1,m2,Z
∗,Y∗,X∗ | θ,ψ) =∏
{i:M2i=1}
p(m1i = 1 | mΩi,ψ)pZ(Z
∗
i | θ)pX(X
∗
i | θ)pY (Y
∗
i | Zi = Z
∗
i , Xi = X
∗
i , θ)
× p(m2i = 1 | m1i = 1, X
∗
i , Y
∗
i ,X
∗,Y∗,ψ)p(M2i = 1 | m2i = 1,ψ)∏
{i:M2i=0,m2i=1}
p(m1i = 1 | mΩi,ψ)
∫
p(Zi | θ)pX(X
∗
i | θ)pY (Yi | Zi, Xi = X
∗
i , θ)dZi
× p(m2i = 1 | m1i = 1, X
∗
i , Y
∗
i ,X
∗,Y∗,ψ)p(M2i = 0 | m2i = 1,ψ)∏
{i:m2i=0,m1i=1}
p(m1i = 1 | mΩi,ψ)
∫
p(Zi | θ)pX(X
∗
i | θ)pY (Yi | Zi, Xi = X
∗
i , θ)dZi
× p(m2i = 0 | m1i = 1, X
∗
i , Y
∗
i ,X
∗,Y∗,ψ)∏
{i:m1i=0}
p(m1i = 0 | mΩi,ψ).
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